Lv4
772 积分 2025-11-11 加入
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
2天前
已完结
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
2天前
已完结
The gut-liver axis in liver disease: Pathophysiological basis for therapy
6天前
已完结
Pathophysiology and therapeutic options for cirrhotic portal hypertension
10天前
已完结
Noncirrhotic Portal Hypertension: Current Concepts and Overview of Causes, Pathophysiology, and Imaging Findings
13天前
已完结
Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension
2个月前
已完结
The intestinal barrier: a pivotal role in health, inflammation, and cancer
2个月前
已完结
Gut-liver axis: Pathophysiological concepts and clinical implications
2个月前
已完结
Interaction of inflammation and portal hypertension in cirrhosis progression
2个月前
已完结
Role of Toll-Like Receptors in Immune Activation and Tolerance in the Liver
2个月前
已完结
皖公网安备34019202002308
